Better Therapeutics, Inc. ( BTTX) - Key Metrics
BTTX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2023Q3 | $0 | -$0.15 | -$0.15 | -$0.15 |
| 2023Q2 | $0 | -$0.24 | -$0.16 | -$0.18 |
| 2023Q1 | $0 | -$0.39 | -$0.37 | -$0.39 |
| 2022Q4 | $0 | -$0.37 | -$0.27 | -$0.28 |
| 2022Q3 | $0 | -$0.48 | -$0.30 | -$0.31 |
BTTX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2023Q3 | 0% | -0.61 |
| 2023Q2 | 0% | -1.13 |
| 2023Q1 | 0% | -0.45 |
| 2022Q4 | 0% | -0.75 |
| 2022Q3 | 0% | -0.92 |
BTTX
Price: $0
52 week price:
Earnings Per Share: -1.10 USD
Exchange: OEM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 41300
Market Capitalization: 5452